New strategies for treatment of heart failure with aldosterone antagonists and the risk of hyperkalaemia

By Cruz Constança S   Cruz Luzia S   Domingues Gustavo S   Marcílio de Souza Carlos A  

Expert Opinion on Drug Safety, Vol. 4, Iss. 4, 2005-07 ,pp. : 677-688

Informa Healthcare

Access to resources Recommend Favorite

Growth hormone and testosterone in heart failure therapy

By Agarwal Megha   Naghi Jesse   Philip Kiran   Phan Anita   Willix Jr Robert D   Schwarz Ernst R  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 11, 2010-08 ,pp. : 1835-1844

Informa Healthcare

Access to resources Recommend Favorite

Growth hormone therapy in heart failure: a novel therapy worthy of further consideration?

By Demers Catherine   McKelvie Robert S  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 8, 2005-08 ,pp. : 1009-1018

Informa Healthcare

Access to resources Recommend Favorite

Discovery of selective CYP11B2 (aldosterone synthase) inhibitors for the therapy of congestive heart failure and myocardial fibrosis

By Hartmann R.W.   Muller U.   Ehmer P.B.  

European Journal of Medicinal Chemistry, Vol. 38, Iss. 4, 2003-04 ,pp. : 363-366

Elsevier

Access to resources Recommend Favorite

Adenosine therapy: a new approach to chronic heart failure

By Kitakaze M.   Hori M.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 11, 2000-11 ,pp. : 2519-2535

Informa Healthcare

Access to resources Recommend Favorite